Chapter 43: Intrauterine Contraception

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, if someone told you they invented a medical device that was just as effective at preventing pregnancy as surgical sterilization.

Oh, wow.

Right, but it was completely reversible the moment the patient changed their mind.

You'd probably assume it would be like the absolute gold standard.

Oh, absolutely.

You'd expect it to be the first line of defense, right?

Like the holy grail of contraception that virtually every patient is asking for.

Exactly.

But when you actually look at the epidemiological data, well, at least here in the U .S., fewer than 10 % of women of childbearing age who use contraception actually choose this method.

That's crazy.

It is.

There is this just a staggering gap between the proven safety of intruder and contraception and its real -world utilization.

It's a massive disconnect, I mean, truly.

And to understand why that gap exists and, more importantly, how clinicians can bridge it, you really have to understand the fraught history of the device.

Right.

Because that history dictates the highly specific zero -tolerance clinical protocols we rely on today.

Yeah, which brings us to the mission for today.

Welcome to this custom -tailored deep dive, everyone.

We are talking directly to you, the advanced practice or nursing student preparing for clinicals.

So glad you're here.

Today, we are translating Chapter 43 on intruder and contraception from the textbook

Advanced Health Assessment of Women.

And look, we're not just going to recite a dry list of clinical steps.

Nobody wants that.

No.

We want to dig into the why behind every protocol in this chapter.

We're looking at the underlying pathophysiology and the clinical rationale so you can actually internalize this for your practice.

Right, because when you're standing in the procedure room, you know, memorization only gets you so far.

You really need to understand the physiological mechanisms you're manipulating.

Totally.

So looking at the modern IUC, the textbook goes out of its way to emphasize one highly specific physical feature.

Oh, the string.

Yes.

Today, all five models available in the U .S.

utilize a two -strand polyethylene monofilament string protruding from the cervical ass.

The chapter literally beats you over the head with the word monofilament.

It really does.

I mean, I get that it means a single solid strand of plastic, but is there a clinical reason the text is so intensely focused on the fact that it isn't braided?

Oh, there absolutely is.

And it's arguably the most important piece of historical context in women's health.

You have to look back at the 1970s and this specific device called the Dalton Shield.

Okay.

Because the Dalton Shield utilized a braided multi -filament tail.

Right.

So multiple tiny threads woven together, much like a standard piece of string or yarn.

Precisely.

And physically, that braided structure was just catastrophic.

It created capillary action.

What does that mean in this context?

Well, because of the microscopic spaces between those braided threads, surface tension basically allowed vaginal fluids to be wicked upward against gravity.

Oh, wow.

Yeah.

The string literally acted as a microscopic ladder, allowing vaginal flora to completely bypass the physical and chemical barrier of the cervical mucus.

Wait, so bacteria were just getting a free ride straight up into a sterile uterine cavity.

A direct unimpeded highway.

And the result was just unprecedented rates of pelvic inflammatory disease.

Oh, PID.

That's awful.

Massive, devastating ascending infections.

It led to severe morbidity, infertility, and as you can imagine, huge medical liability.

Yeah, the lawsuits must have been insane.

They were.

IUC use in the United States plummeted by two -thirds in the 1980s.

The devices were effectively pulled from the market just due to the sheer volume of litigation.

That makes so much sense.

I mean, I always wondered why modern IUC consent forms read like a legal fortress, you know, and why the history -taking process is so exhausting.

It's the ghost of the dog and shield.

Right.

So we use them on a filament string now because a solid piece of plastic eliminates that capillary wicking effect, but those hyper cautious screening protocols from the 80s just never really went away.

Exactly.

The modern devices are incredibly safe, but that history dictates literally everything about how we select and screen patients today.

OK, so speaking of the modern devices, the chapter breaks down the five available options.

And mechanistically, they seem to fall into two very different camps.

First, we have the copper paraguard.

Yes, the only non -hormonal option.

It's a T -shaped plastic frame wound with fine copper wire.

It lasts a long time, right?

It is FDA approved for 10 years.

Though the text does note strong clinical evidence supports off -label use for up to 12 years.

And crucially, it is metabolically neutral.

Right.

But the textbook mentions a common misconception that you really have to clarify with patients.

Paraguard is not an abortifacient.

That is such an important clinical pearl.

Can you explain the actual mechanism of action?

How does just having copper in the uterus prevent pregnancy for over a decade?

It all comes down to a localized inflammatory response.

The device continuously releases free copper ions and copper salts right into the uterine cavity.

OK.

These ions are highly spermicidal.

They interfere with sperm motility, meaning the sperm literally cannot swim properly.

Plus, they disrupt the acrosome reaction.

Which is what, exactly?

It's the chemical process sperm need to undergo to actually penetrate the egg.

So the copper operates primarily by ensuring fertilization never happens in the first place.

The environment just became wildly toxic to sperm.

But because it's creating that localized inflammatory response, I guess that explains the primary disadvantage the text warns about heavier menstrual flow and increased dysmenorrhea.

Right.

That inflammation alters the bleeding pattern, which is actually the number one reason patients request premature removal of a copper IUC.

Good to know.

Now, on the other side of the menu, we have the hormonal options, the Levin or Gestrel or LNG devices, the Textlis, Marina, Skyla, Liletta, and Kyelena.

The chemical remodelers, basically.

Yeah.

If copper acts like a toxic bouncer for sperm, how does the localized progestin work?

I like to think of the LNG devices as fundamentally changing the landscape of the reproductive tract.

Instead of just a barrier, they make the environment entirely inhospitable.

OK.

Well, the continuous low dose of progestin locally down regulates estrogen receptors.

And this does two critical things.

First,

it profoundly thickens the cervical mucus.

Creating a physical plug.

Exactly.

A thick, impenetrable plug that sperm simply cannot swim through.

And second, it alters the endometrium itself, right?

Yes.

Yeah.

Because the estrogen receptors are down regulated, the endometrium undergoes glandular atrophy.

It gets exceedingly thin.

Oh, wow.

So if we imagine the uterus as a lush vascular garden prepared for a fertilized egg to take root, the LNG device basically turns it into an arid, dry desert.

Which perfectly explains the clinical side effects.

If the endometrium is structurally sitting out, there's just less tissue to shed.

The text notes that 20 % of marina users experience complete amenorrhea by year one.

It's not that the blood is trapped or anything.

It's that the lining simply isn't building up in the first place.

Precisely why marina, which is approved for seven years, is also specifically FDA approved as a therapeutic treatment for heavy menstrual bleeding.

Okay, looking at the other three LNGs, there are some very specific distinctions the text points out.

Skyla, for instance, is only approved for three years.

But the text specifically highlights its dimensions.

It's only 28 millimeters horizontally across the T -arms.

Which is a massive clinical advantage when you have a nullaparous patient.

Someone who hasn't been pregnant.

Right.

A uterus that has never undergone pregnancy is significantly smaller.

And a standard 32 -millimeter device can cause severe cramping and displacement.

Skyla's smaller frame makes it much easier to deploy in that tighter cavity space.

That makes total sense.

The other two are Liletta and Kylinna.

Kylinna lasts for five years and has a silver ring on the stem.

Is that purely for imaging?

Yes.

The silver ring is highly echogenic.

It acts as a distinct marker so that on an ultrasound, you can immediately differentiate Kylinna from the other LNG models.

Which would be crucial for verifying exactly which device a patient has if they, transfer their care to you.

Exactly.

And Liletta, which lasts for three years, has a very specific timing rule.

Oh, right.

The text emphasizes not inserting it during the first seven days of the menstrual cycle.

Which implies we need to be very aware of the physiological timeline for hormone efficacy.

Spot on.

It's all about when the local progestin reaches a steady therapeutic state to properly alter that cervical mucus.

Okay.

So we know our device menu intimately.

Let's talk about patient selection and contraindications, because the textbook actually had a few surprises for me.

Oh, like what?

Well, obviously active pregnancy, unexplained vaginal bleeding, certain anatomical anomalies,

and untreated acute cervicitis like chlamydia or gonorrhea.

Those are hard stops.

But I want to push back on one thing.

Go for it.

The text explicitly states that a past history of pelvic inflammatory disease is not a contraindication.

If a patient has a history of a massive upper tract infection that could have caused scarring, why on earth are we green lighting an IUC?

It's a very common hesitation among clinicians, but it really comes down to active versus resolved pathology.

A past episode of PID, assuming it was successfully treated and resolved, means the effective infection is gone.

The IUC itself doesn't spontaneously generate PID.

PID is caused by introducing new pathogens like GC or chlamydia into the upper tract.

Right.

So as long as the patient's current risk factors for STIs are low and their current screening is negative, the resolved scarring from past PID doesn't increase their risk of a new infection from the device.

That makes sense.

We are guarding against active pathogens, not past immunological battles.

Exactly.

And similarly, the text busts another persistent clinical myth regarding HIV.

Yes, the CDC updated their medical eligibility criteria years ago, but many clinicians still hesitate.

HIV is not a contraindication.

Really good to clarify.

An HIV positive patient, especially one well managed on antiretrovirals, can absolutely safely use an IUC.

So assuming our patient clears the history, we move to the pre -insertion assessment.

I noticed the textbook advocates for inserting the device during menses.

Mechanistically, I know the OSS is slightly dilated, but isn't there a competing risk there?

Blood is an excellent culture medium.

You're highlighting the exact clinical trade -off.

Yes, the cervical OSS is naturally open during menses, making the physical passing of the sounding tool and the insertion tube much easier.

And probably significantly less painful for the patient.

Absolutely.

But because menstrual blood alkalizes the vaginal pH and acts as a biological medium, the text does acknowledge a marginally higher risk of infection and expulsion.

However,

the ease of insertion and the absolute certainty that the patient isn't pregnant usually outweigh that minimal risk increase.

What if they just had a baby?

Postpartum insertion timing is all about uterine involution.

You generally wait four to eight weeks.

Because the uterus is still shrinking.

Exactly.

If you attempt insertion in a boggy, massive, uncontracted uterus, the expulsion rate skyrockets, and the perforation risk is dangerously high because the myometrium is so soft.

And for Kailena specifically, the text mandates waiting for complete uterine involution.

Now, before you even open the sterile packaging, the protocol mandates a bimanual exam.

I know we do this to determine the size, shape, and position of the uterus.

But I want to underline why this is so critical.

The textbook issues a pretty stark warning about perforation.

It does.

The majority of uterine perforations don't happen because the clinician used too much force.

They happen because the clinician was driving blind.

What do you mean?

Well, if the uterus is acutely antiflexed or retroflexed, and you just assume it's in a neutral midline position, you will drive that rigid plastic insertion tube straight through the anterior or posterior wall of the myometrium.

Yikes.

The bimanual exam is your only topological map.

You have to know the exact angle of the cavity before you instrument it.

Concurrently, we are looking at the STI screening pathways, the text uses the CDC guidelines, and the decision tree is fascinating.

It really is.

If you do a wet mount and see elevated white blood cells, or if you get a positive swab for gonorrhea or chlamydia, you stop the procedure immediately.

You treat and you delay insertion.

But if that wet mount comes back positive for bacterial vaginosis BV,

the text says you can just proceed with insertion.

Yes.

Why the discrepancy?

Why is BV acceptable but chlamydia isn't?

Comes down to the niche or the microorganisms.

Gonorrhea and chlamydia are aggressive ascending pathogens.

Right.

If they are in the cervix, the instrumentation of insertion will literally push them straight up into the sterile fundus, rapidly causing PID.

Which we want to avoid at all costs.

Exactly.

Bacterial vaginosis, however, isn't an introduced ascending pathogen.

It's a dysbiosis.

Just an imbalance.

Right.

An overgrowth of the normal anaerobic flora already present in the vagina.

The risk of that dysbiosis aggressively ascending and causing a systemic inflammatory response is drastically lower.

That is a phenomenal distinction.

So the protocol allows you to insert the IUC and concurrently treat the BV with oral metronidazole.

Okay.

The history is clear.

The exam is done.

The wet mount is acceptable.

Let's step into the procedure itself.

The text stresses that you must move slowly and deliberately to prevent vasovagal syncope.

Yes.

Fainting.

Urologically, why is the cervix so reactive that it can literally cause a patient to pass out on the table?

The cervix is highly innervated by the parasympathetic nervous system.

Specifically, branches of the vagus nerve.

When you physically grasp the cervix or mechanically stretch the internal osse with a dilator or an insertion tube, you can trigger a massive vagal response.

Wow.

This causes a sudden profound bradycardia and a huge drop in blood pressure.

The brain literally just cuts the power.

Exactly.

It happens most frequently in molipers patients where the osse is very tight or if the patient is highly anxious or fasting.

Slow, gentle instrumentation minimizes that abrupt vagal stimulation.

Good to know.

So step one of instrumentation, the tenaculum.

We place the single -toothed instrument 1 .5 to 2 .0 centimeters from the osse to grasp the anterior lip.

And the text specifies placement at 10 and 2 o 'clock for an anteverted uterus and 4 and 8 o 'clock for a retroverted one.

The purpose here is traction.

Yes.

Because the uterine cavity doesn't sit in a perfectly straight alignment with the vaginal canal.

There is a sharp angle at the lower uterine segment.

I always visualize it like an accordion.

Oh, I like that.

Yeah.

If you have a bent accordion, you can't shove a rigid rod through it without tearing right through the folds.

You have to pull both ends of the accordion to stretch it perfectly straight.

Applying traction with the tenaculum pulls that lower uterine segment taut.

It aligns the cervical canal with the endometrial cavity so your instruments can glide in safely.

That's a perfect biomechanical analogy.

Thanks.

And once that canal is straight, you introduce the sterile uterine sound to measure the depth from the external os all the way to the fundus.

And here we hit a critical clinical decision point based on the text.

We are looking for a sounding depth between 6 and 10 centimeters.

What physically happens if we sound the uterus and it's, say, only 5 centimeters?

If the cavity is less than 6 centimeters, the physical dimensions of the IUC will exceed the available space.

It just won't fit.

Right.

The t -arms will constantly press against the lateral walls of the myometrium.

That leads to severe intractable cramping, abnormal bleeding, and a massively high risk of the uterus simply contracting and expelling the device.

And conversely, what if we sound the uterus and it's 11 or 12 centimeters deep?

Then you have a cavity that is too large.

The device relies on occupying a specific spatial volume at the fundus to alter the local environment.

If the cavity is too large, the IUC might displace downward or just float around, which drastically decreases its contraceptive efficacy.

Okay.

Assuming we are perfectly in that 6 to 10 centimeter window, we load the device and the textbook highlights a manufacturer quirk that could easily trip up a busy clinician.

Oh, the folding.

Yeah.

If you are inserting the copper pair guard, the t -arms must be folded downward into the insertion tube.

But for Marina, Skyla, Loletta, and Kailena, the arms fold upward.

It seems like trivial trivia.

But if you load a device backward against its hinge memory, it will not deploy correctly.

Really?

Yeah.

It can get stuck in the tube or fail to open fully at the fundus,

which completely compromises the procedure.

Okay.

So you advance the tube to the sounding depth, deploy the arms, remove your instruments, and take your sterile scissors to trim the monofilament strings to exactly three centimeters outside the external os.

And you're done.

Well, with the procedure.

Right.

Because as we discussed with the vagus nerve, you don't just send them to their car right away.

You have them stand up in the room and observe them to ensure delayed syncope doesn't occur.

Which transitions us smoothly into post -insertion care.

The physical procedure is only half the battle.

Patient education really dictates the long -term success of the method.

And the textbook is very prescriptive here.

We need to teach the patient how to assess their own device.

They should feel for the strings after every menses, either sitting on the toilet, squatting, or standing with one leg elevated.

But the strict instruction is, feel, do not pull.

Exactly.

Because even gentle traction can displace it into the lower uterine segment.

We also need to set realistic physiological expectations.

Because we just instrumented the cervix and introduced a foreign body,

prostaglandin release is going to cause cramping.

The text recommends NSAIDs, like ibuprofen, for one to three days.

And NSAIDs are specifically recommended over acetaminophen because they actively inhibit that prostaglandin cascade.

They treat the physiological cause of the cramps, not just masking the pain.

We also instruct them to avoid tampons for 48 hours, to minimize any risk of bacterial interruption while the cervix is still recovering from the dilation.

And we have to counsel on being heavier for copper, irregular than lighter for LNGs.

Plus, the mandatory reminder,

this device provides absolutely zero protection against STIs.

Absolutely.

And from a medical legal standpoint, your documentation of this visit needs to be flawless.

You must chart the uterine size, shape, and position.

You chart the exact sounding depth, the specific IUC type, the lot number, the exact length you trim the strings to, and the patient's tolerance of the procedure.

Because if a complication arises six months down the line, that detailed chart is your baseline.

Exactly.

Speaking of complications, the chapter covers several post -insertion issues, and I really want to walk through the clinical management of a few of them.

First up,

a patient comes in for a follow -up,

and you look at the cervix, and the strings are just gone.

Missing strings trigger a very specific differential diagnosis.

It doesn't automatically mean the device perforated the uterus.

So don't panic right away.

Right.

The strings could have simply retracted upward into the endocervical canal as the uterus shifted, or the device may have rotated 180 degrees in the fundus, pulling the strings up, or it was expelled without the patient even noticing.

So the text outlines a step management approach.

First, you gently insert a cider brush into the endocervical canal, twirl it, and see if you can snag the strings and pull them back through the os.

Exactly.

Always start with the least invasive mechanical option.

But if that cider brush comes back empty,

you absolutely do not blind probe the cavity with forceps.

No fishing around blindly.

Never.

You immediately order a transvaginal ultrasound, preferably 3D, to definitively locate the hardware.

Okay, here's a scenario from the text that genuinely shocked me.

You get a routine pap smear back on an IUC patient, and the pathology flags the presence of actinomyces.

Well, yes.

Now, actinomyces is an anaerobic bacterium, but the text states that if the patient is totally asymptomatic, you literally do nothing.

You just leave it alone.

How is leaving colonized bacteria on a foreign body acceptable clinical practice?

It feels incredibly counterintuitive, doesn't it?

But you have to separate colonization from tissue invasion.

Actinomyces is a commensal bacterium.

It naturally lives in the reproductive tract of many women.

It loves to aggregate on the surface of foreign bodies like IUCs.

It will actually show up on about 7 % of users' pap smears.

But unless there is a breakdown in the mucosal barrier allowing those bacteria to invade the deeper tissue, it does not cause an active infection.

It's just living there.

So treating asymptomatic colonization would basically just be hammering the patient with unnecessary antibiotics, breeding resistance for no reason.

Precisely.

However, and this is key, if that patient presents with pelvic pain, fever, or abnormal discharge alongside that pap result, the clinical picture changes entirely.

Now you have active tissue invasion.

Yes.

In that symptomatic scenario, you must remove the device immediately and start the patient on a prolonged course of oral penicillin, usually for a month.

What about the absolute worst case scenario?

The patient gets pregnant with an IUC in place.

We know the device is incredibly effective, but failures do happen.

When an IUC fails, the physiological reality is that it is highly effective at preventing implantation in the uterus, but it does absolutely nothing to prevent implantation in the fallopian tubes.

Therefore, if a patient with an IUC test positive for pregnancy, the statistical ratio shifts dangerously.

You must assume it is an ectopic pregnancy until proven otherwise.

A stat ultrasound is absolutely mandatory.

Let's say the ultrasound clears the fallopian tubes, and incredibly, there is an intact gestational sac safely in the uterus right next to the IUC.

The text is very aggressive here.

It states the IUC must be removed, but won't pulling the device out disrupt the pregnancy and cause a miscarriage?

It might, and you must extensively counsel the patient on that risk.

But the alternative is far worse.

Leaving a foreign body inside a pregnant uterus exponentially increases the risk of premature rupture of membranes, spontaneous septic abortion, and overwhelming life -threatening maternal sepsis.

So you have to weigh the risks?

Yes.

The mechanical risk of pulling it out is vastly preferable to the infectious risk of leaving it in.

Which brings us to the actual removal process, whether it's for a complication, or the patient wants to conceive, or the 10 years are simply up.

Thankfully, removal is generally entirely uncomplicated compared to insertion.

You visualize the onus, grasp the monofilament strings securely with ring forceps, and apply steady, continuous downward traction until the arms fold back and the device glides out.

And the textbook has a brilliant neurological trick for this.

Right as you begin to apply traction, you instruct the patient to give a hard, sharp cough.

I love this trick.

It's the gate control theory of pain in action.

The sudden explosive cough increases intra -abdominal pressure, pushing the uterus downwards slightly.

But more importantly, it completely floods the central nervous system with competing sensory inputs.

It distracts the brain so effectively that the patient often doesn't even register the pinch of the device passing through the internal loss.

But once it's out, your job isn't done.

You can't just toss it in the biohazard bin.

You have to meticulously inspect the device against a good light source.

You are verifying that both T -arms are intact, the stem is solid, and nothing snapped off.

Absolutely crucial.

Because a fragment of polyethylene left behind in the endometrium can cause chronic pain, abnormal bleeding, and secondary infertility.

Every single step from assessing a history of PID to feeling the tension on the tenaculum to inspecting the removed plastic all requires active, engaged clinical reasoning.

We've covered everything in Chapter 43 today.

We've mapped out the physical layout of the devices, the deep pathophysiology of the hormones in copper,

the neurological traps in the procedure room, and the strict protocols that keep our patients safe.

And if we step back from the textbook for a moment, it leaves us with a really fascinating,

provocative thought for the future.

We spent a lot of time today discussing how the history of the Dalekin shield and its braided string basically forced the invention of the monofilament string, completely dictating our modern protocols.

Right.

Our current practice is essentially a reaction to the failed technology of the 1970s.

So what does the next paradigm shift look like?

Imagine a near future where we completely eliminate the string.

Oh, wow.

What if, instead of relying on a monofilament tail that we have to blindly fish for with a cytobrush, we utilize dissolvable biometric polymers or devices embedded with micro -RFID tags that allow you to hold a smartphone over the patient's abdomen to instantly verify millimeter -accurate placement and remaining hormone levels.

That would entirely rewrite Chapter 43.

Completely.

It would eliminate the need for transvaginal ultrasounds for missing strings.

And it would eliminate the string -check anxiety for the patient altogether.

Exactly.

The clinical protocols we study today aren't the finish line.

They're just the current state of the art.

That is an incredible thought to take into clinicals this week.

To all of you studying alongside us today, thank you for joining us.

Remember, you won't always have an MRI to show you exactly what is happening inside the cavity, but with a rigorous history, a precise bimanual exam, and a deep understanding of the pathophysiology, you have all the tools you need.

We'll catch you on the next deep dive from all of us here at the Last Minute Lecture Team.